Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $32.87, denoting a +0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily ...

Life in the digital world can be rewarding. It’s convenient to order groceries for pickup, share photographs or music, and keep in touch with family and friends, no matter the distance. However, it ...

like single-session interventions and digital therapeutics. As telehealth platforms grow, they may be attracting clinicians from community settings with the promise of flexible hours and better ...

Digital technologies are playing a crucial role in sustainable development. From AI-enabled health and education tools to digital public infrastructure, they are helping to unlock innovation and ...

Revance Therapeutics, Inc. faces financial struggles and competition, leading to a proposed takeover by Crown Labs, initially valued at $6.66 per share, later reduced to $3.10. Teoxane ...

The bad news is that the bloom may be coming off the GLP-1 rose, which is presumably the reason why not only Eli Lilly but Novo Nordisk and Viking Therapeutics stock are suffering this morning.

Despite the competitive threat posed by Eli Lilly’s acquisition of Scorpion Therapeutics’ STX-478, which has shown promising efficacy in several cancer types, Relay Therapeutics’ RLY-2608 ...